Key Highlights

  • Ultralife (NASDAQ:ULBI) closed up about 145% on October 28, 2026, the first full session after EnerSys agreed to buy it for USD 16 per share in cash, a 166% premium.
  • The deal values Ultralife (NASDAQ:ULBI) at an enterprise value of about USD 320 million, and EnerSys expects USD 15 million to USD 20 million of synergies, per the 8-K and press release.
  • EnerSys will use a cash tender offer, with closing expected in the first calendar quarter of 2027, so shareholders face months of timing and approval risk.
  • The deal was announced October 27, 2026. The close of up 145.44% comes from one recap, and our arithmetic puts it near USD 14.76, about 8% below the offer.

What EnerSys Agreed to Pay

EnerSys agreed to acquire Ultralife (NASDAQ:ULBI) for USD 16 per share in cash, according to the Ultralife 8-K and press release. The company said the price is a 166% premium and implies an enterprise value of about USD 320 million. The agreement was announced on October 27, 2026, so October 28 was the first full trading session with the news priced in. One recap puts the close at up 145.44%. Simple arithmetic on the 166% premium implies an unaffected price near USD 6.02, and applying the 145.44% gain gives a close near USD 14.76. Both are our own estimates and approximate because the underlying published figures are rounded, and the 145.44% close comes from a single recap.

How a Tender Offer and Synergies Work

In a cash tender offer, the buyer asks shareholders to sell their shares directly, usually with a minimum participation condition, instead of waiting for a shareholder meeting. It can be faster than a traditional merger vote, though regulatory clearance is still needed before shares are bought. EnerSys expects USD 15 million to USD 20 million of synergies, meaning cost savings or revenue gains from combining the businesses. Those are company targets, not results. The gap between the market price and USD 16 is the market's allowance for time, approval and the chance the deal does not close. On our arithmetic that gap is roughly USD 1.24 per share.

Risks and What to Watch

The first calendar quarter of 2027 is the expected close, which leaves several months for something to change, including interest rates and the wider market backdrop. Risks include regulatory review, too few shares being tendered, a competing offer and any deterioration in either company's results or financing arrangements. Ultralife (NASDAQ:ULBI) shareholders who sell now give up the remaining spread, while those who wait carry deal risk. A 145% jump also means the stock now trades on the offer rather than on its own fundamentals, so a break in the deal could reverse much of the gain. Watch for the tender offer launch date, the minimum condition, any regulatory filings and the Hart-Scott-Rodino waiting period.

Where Things Stand

The surge reflects a cash buyout at a steep premium. Ultralife (NASDAQ:ULBI) jumped about 145% on October 28, 2026 because EnerSys agreed on October 27 to pay USD 16 per share, 166% above the prior price, in a tender offer valuing the company near USD 320 million including debt. The shares still trade below the offer because closing is expected only in the first calendar quarter of 2027 and approvals are pending. The next steps are the tender offer launch and regulatory clearance.